Active Pharmaceutical Ingredients
Recent Highlights
All Stories for Active Pharmaceutical Ingredients
Lupin's Mandideep Unit II facility in Madhya Pradesh receives EIR from USFDA
•Pharma major Lupin on Wednesday said it has received an establishment inspection report (EIR) from the US health regulator for its Mandideep Unit II facility in Madhya Pradesh
Coronavirus outbreak: Govt restrains exports of a few APIs, formulations; lists essential medicines that could run out of stock
Fp Staff •In a notification, the government put curbs on the exports of certain APIs and formulations, including Paracetamol, Vitamin B1 and B12 amid the coronavirus outbreak claimed over 3,000 lives across the world.
Coronavirus outbreak: ICRA revises domestic pharma industry outlook to negative amid lockouts in parts of China
•The domestic pharma industry is highly dependent on imports, with more than 60 percent of its active pharmaceutical ingredients (API) requirement being shipped from overseas locations, especially China.
India-Pakistan air strikes: Drug exporters wary of tension between two countries, apprehensive about future
•The Indian pharmaceutical companies exports over $140 million to Pakistan with 50 percent active pharmaceutical ingredients.
Eight Chinese pharma cos to be blacklisted for quality issues, may lead to shortage of medicines
Ians •The Indian government has issued show cause notices to, and may soon blacklist, eight Chinese pharmaceutical companies found to be supplying poor quality raw material to drug manufacturers in this country
Dr Reddy's gets a breather after USFDA gives more time to respond to warning letter
Fp Archives •The country's second-largest drug maker last week said it received a warning letter from the US drug regulator relating to two of its API manufacturing plants and a formulation plant located in Andhra Pradesh and Telangana.